161 related articles for article (PubMed ID: 30306857)
1. Role of Fatty Acid Binding Protein 4 (FABP4) in Kidney Disease.
Shi M; Ma L; Fu P
Curr Med Chem; 2020; 27(22):3657-3664. PubMed ID: 30306857
[TBL] [Abstract][Full Text] [Related]
2. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
Furuhashi M
J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
Furuhashi M; Saitoh S; Shimamoto K; Miura T
Clin Med Insights Cardiol; 2014; 8(Suppl 3):23-33. PubMed ID: 25674026
[TBL] [Abstract][Full Text] [Related]
4. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P
Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction.
Tanaka M; Furuhashi M; Okazaki Y; Mita T; Fuseya T; Ohno K; Ishimura S; Yoshida H; Miura T
Nephron Clin Pract; 2014; 128(3-4):345-51. PubMed ID: 25592475
[TBL] [Abstract][Full Text] [Related]
7. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid-binding protein 4 in kidney diseases: From mechanisms to clinics.
Lai W; Shi M; Huang R; Fu P; Ma L
Eur J Pharmacol; 2022 Sep; 931():175224. PubMed ID: 35995212
[TBL] [Abstract][Full Text] [Related]
9. Circulating FABP4 is eliminated by the kidney via glomerular filtration followed by megalin-mediated reabsorption.
Shrestha S; Sunaga H; Hanaoka H; Yamaguchi A; Kuwahara S; Umbarawan Y; Nakajima K; Machida T; Murakami M; Saito A; Tsushima Y; Kurabayashi M; Iso T
Sci Rep; 2018 Nov; 8(1):16451. PubMed ID: 30401801
[TBL] [Abstract][Full Text] [Related]
10. Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.
Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Matsumoto M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Circ J; 2018 Mar; 82(4):1121-1129. PubMed ID: 29445067
[TBL] [Abstract][Full Text] [Related]
11. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.
Okazaki Y; Furuhashi M; Tanaka M; Mita T; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
PLoS One; 2014; 9(12):e115429. PubMed ID: 25506691
[TBL] [Abstract][Full Text] [Related]
13. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.
Trojnar M; Patro-Małysza J; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B; Mosiewicz J
Cells; 2019 Mar; 8(3):. PubMed ID: 30857223
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological Insight into Fatty Acid-Binding Protein-4: Multifaced Roles in Reproduction, Pregnancy, and Offspring Health.
Shi Y; Wang CC; Wu L; Zhang Y; Xu A; Wang Y
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628833
[TBL] [Abstract][Full Text] [Related]
15. A New Insight into Fatty Acid Binding Protein 4 Mechanisms and Therapeutic Implications in Obesity-Associated Diseases: A Mini Review.
Başarır Sivri FN; Çiftçi S
Mol Nutr Food Res; 2024 Apr; 68(8):e2300840. PubMed ID: 38593305
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levels.
Lamounier-Zepter V; Look C; Ehrhart-Bornstein M; Bornstein SR; Fischer S; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):129-34. PubMed ID: 23357154
[TBL] [Abstract][Full Text] [Related]
17. Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease.
Rodríguez-Calvo R; Girona J; Alegret JM; Bosquet A; Ibarretxe D; Masana L
J Endocrinol; 2017 Jun; 233(3):R173-R184. PubMed ID: 28420707
[TBL] [Abstract][Full Text] [Related]
18. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
Lamounier-Zepter V; Look C; Alvarez J; Christ T; Ravens U; Schunck WH; Ehrhart-Bornstein M; Bornstein SR; Morano I
Circ Res; 2009 Aug; 105(4):326-34. PubMed ID: 19608978
[TBL] [Abstract][Full Text] [Related]
19. Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.
Furuhashi M; Hiramitsu S; Mita T; Omori A; Fuseya T; Ishimura S; Watanabe Y; Hoshina K; Matsumoto M; Tanaka M; Moniwa N; Yoshida H; Ishii J; Miura T
Lipids Health Dis; 2016 Jan; 15():5. PubMed ID: 26754658
[TBL] [Abstract][Full Text] [Related]
20. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
